The contribution of cancer incidence, stage at diagnosis and survival to racial differences in years of life expectancy

Mitchell D Wong, Susan L Ettner, W John Boscardin, Martin F Shapiro, Mitchell D Wong, Susan L Ettner, W John Boscardin, Martin F Shapiro

Abstract

Background: African Americans have higher cancer mortality rates than whites. Understanding the relative contribution of cancer incidence, stage at diagnosis and survival after diagnosis to the racial gap in life expectancy has important implications for directing future health disparity interventions toward cancer prevention, screening and treatment.

Objective: We estimated the degree to which higher cancer mortality among African Americans is due to higher incidence rates, later stage at diagnosis or worse survival after diagnosis.

Design: Stochastic model of cancer incidence and survival after diagnosis.

Patients: Surveillance and Epidemiology End Result cancer registry and National Health Interview Survey data.

Measurements: Life expectancy if African Americans had the same cancer incidence, stage and survival after diagnosis as white adults.

Results: African-American men and women live 1.47 and 0.91 fewer years, respectively, than whites as the result of all cancers combined. Among men, racial differences in cancer incidence, stage at diagnosis and survival after diagnosis account for 1.12 (95% CI: 0.52 to 1.36), 0.17 (95% CI: -0.03 to 0.33) and 0.21 (95% CI: 0.05 to 0.34) years of the racial gap in life expectancy, respectively. Among women, incidence, stage and survival after diagnosis account for 0.41 (95% CI: -0.29 to 0.60), 0.26 (95% CI: -0.06 to 0.40) and 0.31 (95% CI: 0.05 to 0.40) years, respectively. Differences in stage had a smaller impact on the life expectancy gap compared with the impact of incidence. Differences in cancer survival after diagnosis had a significant impact for only two cancers-breast (0.14 years; 95% CI: 0.05 to 0.16) and prostate (0.05 years; 95% CI 0.01 to 0.09).

Conclusions: In addition to breast and colorectal cancer screening, national efforts to reduce disparities in life expectancy should also target cancer prevention, perhaps through smoking cessation, and differences in survival after diagnosis among persons with breast and prostate cancer.

Figures

Figure 1
Figure 1
Racial difference (white-African American) in years of life expectancy (LE) among men attributable to racial differences in cancer incidence, stage at presentation and survival after cancer diagnosis. *p 

Figure 2

Racial difference (white-African American) in…

Figure 2

Racial difference (white-African American) in years of life expectancy (LE) among women attributable…

Figure 2
Racial difference (white-African American) in years of life expectancy (LE) among women attributable to racial differences in cancer incidence, stage at presentation and survival after cancer diagnosis. *p 

Figure 3

Comparison of SEER and NHIS…

Figure 3

Comparison of SEER and NHIS data on years of potential life lost (YPLL)…

Figure 3
Comparison of SEER and NHIS data on years of potential life lost (YPLL) due to specific cancers and all cancers combined. YPLL = years of potential life lost before age 75 per 1,000 persons, calculated as , where n is the number of persons at risk for death in the population. Other GI = other gastrointestinal cancers, including esophageal, pancreatic and liver.
Similar articles
Cited by
References
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0895-4356(00)00316-4', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0895-4356(00)00316-4'}, {'type': 'PubMed', 'value': '11297886', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/11297886/'}]}
    2. Marcella S, Miller JE. Racial differences in colorectal cancer mortality. The importance of stage and socioeconomic status. J Clin Epidemiol. 2001;54:359–66. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '2018022', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/2018022/'}]}
    2. Ragland KE, Selvin S, Merrill DW. Black-white differences in stage-specific cancer survival: analysis of seven selected sites. Am J Epidemiol. 1991;133:672–82. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0029-7844(99)00334-8', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0029-7844(99)00334-8'}, {'type': 'PubMed', 'value': '10511350', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/10511350/'}]}
    2. Howell EA, Chen YT, Concato JRD. Differences in cervical cancer mortality among black and white women. Obstet Gynecol. 1999;94:509–15. - PubMed
    1. Gadgeel SM, Kalemkerian GP. Racial differences in lung cancer. In: Cancer Metastasis Rev; 2003:39–46. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC1089022', 'is_inner': False, 'url': 'http://www.ncbi.nlm.nih.gov/pmc/articles/pmc1089022/'}, {'type': 'PubMed', 'value': '10357289', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/10357289/'}]}
    2. Potosky AL, Merrill RM, Riley GF, et al. Prostate cancer treatment and 10-year survival among group/staff HMO and fee-for-service Medicare patients. Health Serv Res. 1999;34:525–46. - PMC - PubMed
Show all 52 references
Publication types
MeSH terms
Full text links [x]
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM
Figure 2
Figure 2
Racial difference (white-African American) in years of life expectancy (LE) among women attributable to racial differences in cancer incidence, stage at presentation and survival after cancer diagnosis. *p 

Figure 3

Comparison of SEER and NHIS…

Figure 3

Comparison of SEER and NHIS data on years of potential life lost (YPLL)…

Figure 3
Comparison of SEER and NHIS data on years of potential life lost (YPLL) due to specific cancers and all cancers combined. YPLL = years of potential life lost before age 75 per 1,000 persons, calculated as , where n is the number of persons at risk for death in the population. Other GI = other gastrointestinal cancers, including esophageal, pancreatic and liver.
Figure 3
Figure 3
Comparison of SEER and NHIS data on years of potential life lost (YPLL) due to specific cancers and all cancers combined. YPLL = years of potential life lost before age 75 per 1,000 persons, calculated as , where n is the number of persons at risk for death in the population. Other GI = other gastrointestinal cancers, including esophageal, pancreatic and liver.

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0895-4356(00)00316-4', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0895-4356(00)00316-4'}, {'type': 'PubMed', 'value': '11297886', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/11297886/'}]}
    2. Marcella S, Miller JE. Racial differences in colorectal cancer mortality. The importance of stage and socioeconomic status. J Clin Epidemiol. 2001;54:359–66.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '2018022', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/2018022/'}]}
    2. Ragland KE, Selvin S, Merrill DW. Black-white differences in stage-specific cancer survival: analysis of seven selected sites. Am J Epidemiol. 1991;133:672–82.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0029-7844(99)00334-8', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0029-7844(99)00334-8'}, {'type': 'PubMed', 'value': '10511350', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/10511350/'}]}
    2. Howell EA, Chen YT, Concato JRD. Differences in cervical cancer mortality among black and white women. Obstet Gynecol. 1999;94:509–15.
    1. Gadgeel SM, Kalemkerian GP. Racial differences in lung cancer. In: Cancer Metastasis Rev; 2003:39–46.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC1089022', 'is_inner': False, 'url': 'http://www.ncbi.nlm.nih.gov/pmc/articles/pmc1089022/'}, {'type': 'PubMed', 'value': '10357289', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/10357289/'}]}
    2. Potosky AL, Merrill RM, Riley GF, et al. Prostate cancer treatment and 10-year survival among group/staff HMO and fee-for-service Medicare patients. Health Serv Res. 1999;34:525–46.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0090-4295(99)00564-6', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0090-4295(99)00564-6'}, {'type': 'PubMed', 'value': '10792091', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/10792091/'}]}
    2. Merrill RM, Lyon JL. Explaining the difference in prostate cancer mortality rates between white and black men in the United States. Urology. 2000;55:730–5.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.2105/AJPH.94.5.803', 'is_inner': False, 'url': 'https://doi.org/10.2105/ajph.94.5.803'}, {'type': 'PMC', 'value': 'PMC1448341', 'is_inner': False, 'url': 'http://www.ncbi.nlm.nih.gov/pmc/articles/pmc1448341/'}, {'type': 'PubMed', 'value': '15117704', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15117704/'}]}
    2. Freeman VL, Durazo-Arvizu R, Keys LC, Johnson MP, Schafernak K, Patel VK. Racial differences in survival among men with prostate cancer and comorbidity at time of diagnosis. Am J Public Health. 2004;94:803–8.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9107433', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/9107433/'}]}
    2. Cooper GS, Yuan Z, Rimm AA. Racial disparity in the incidence and case-fatality of colorectal cancer: analysis of 329 United States counties. Cancer Epidemiol Biomarkers Prev. 1997;6:283–5.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1097/00005650-200502000-00007', 'is_inner': False, 'url': 'https://doi.org/10.1097/00005650-200502000-00007'}, {'type': 'PubMed', 'value': '15655427', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15655427/'}]}
    2. Elmore JG, Nakano CY, Linden HM, Reisch LM, Ayanian JZ, Larson EB. Racial Inequities in the Timing of Breast Cancer Detection, Diagnosis, and Initiation of Treatment. Med Care. 2005;43:141–8.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.3322/canjclin.48.1.31', 'is_inner': False, 'url': 'https://doi.org/10.3322/canjclin.48.1.31'}, {'type': 'PubMed', 'value': '9449932', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/9449932/'}]}
    2. Parker SL, Davis KJ, Wingo PA, Ries LA, Heath CW Jr. Cancer statistics by race and ethnicity. CA Cancer J Clin. 1998;48:31–48.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.2105/AJPH.2005.077628', 'is_inner': False, 'url': 'https://doi.org/10.2105/ajph.2005.077628'}, {'type': 'PMC', 'value': 'PMC1698151', 'is_inner': False, 'url': 'http://www.ncbi.nlm.nih.gov/pmc/articles/pmc1698151/'}, {'type': 'PubMed', 'value': '17077411', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/17077411/'}]}
    2. Kilbourne AM, Switzer G, Hyman K, Crowley-Matoka M, Fine MJ. Advancing health disparities research within the health care system: a conceptual framework. Am J Public Health. 2006;96:2113–21.
    1. Agency for Healthcare Research and Quality. 2006 National Healthcare Disparities Report. Rockville, MD: US Department of Health and Human Services, Agency for Healthcare Research and Quality; 2006.
    1. Agency for Healthcare Research and Quality. 2007 National Healthcare Disparities Report. Rockville, MD: US Department of Health and Human Services, Agency for Healthcare Research and Quality; 2007.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJMsa012979', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejmsa012979'}, {'type': 'PubMed', 'value': '12432046', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/12432046/'}]}
    2. Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to disparities in mortality. N Engl J Med. 2002;347:1585–92.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1097/01.mlr.0000178196.14532.40', 'is_inner': False, 'url': 'https://doi.org/10.1097/01.mlr.0000178196.14532.40'}, {'type': 'PubMed', 'value': '16166877', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/16166877/'}]}
    2. Wong MD, Tagawa T, Hsieh HJ, Shapiro MF, Boscardin WJ, Ettner SL. Differences in cause-specific mortality between Latino and white adults. Med Care. 2005;43:1058–62.
    1. National Center for Health Statistics. National Health Interview Survey, Part1. 1994. Springfield, VA: National Technical Information Service; 1994 (database).
    1. None
    2. National Center for Health Statistics. National Health Interview Surveys, 1986-1997: Multiple Cause of Death, 1986-1997. Hyattsville, MD: US Department of Health and Human Services; 2000.
    1. Surveillance, Epidemiology, and End Result (SEER) Program () Public-Use Data (1973–2000). Released April 2003, based on the November 2002 submission: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Last accessed Jan 5, 2009.
    1. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975–2002. . In. Bethesda, MD: National Cancer Institute; 2005. Last accessed Jan 5, 2009.
    1. None
    2. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia: Lippincott-Raven; 1998.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1007/BF01890836', 'is_inner': False, 'url': 'https://doi.org/10.1007/bf01890836'}]}
    2. Cleveland WS, Grosse E. Computational methods for local regression. Stat Comput. 1991;1:47–62.
    1. None
    2. Hougaard P. Analysis of Multivariate Survival Data. New York, NY: Springer-Verlag; 2000.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '12583542', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/12583542/'}]}
    2. Arias E. United States life tables, 2000. Natl Vital Stat Rep. 2002;51:1–38.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.2307/2669316', 'is_inner': False, 'url': 'https://doi.org/10.2307/2669316'}]}
    2. King G, Tomz M, Wittenberg J. Making the most of statistical analyses: improving interpretation and presentation. Am J Polit Sci. 2000;44:341–55.
    1. Anderson RN, Rosenberg HM. Age standardization of death rates: Implementation of the year 2000 standard. In: National Vital Statistics Reports. Hyattsville, Maryland: National Center for Health Statistics; 1998.
    1. Hoyert DL, Kochanek KD, Murphy SL. Deaths: Final data for 1997. In: National Vital Statistics Reports. Hyattsville, MD: National Center for Health Statistics; 1999:1–105.
    1. Murphy SL. Deaths: Final Data for 1998. In: National vital statistics reports. Hyattsville, Maryland: National Center for Health Statistics; 2000.
    1. Hoyert DL, Arias E, Smith BL, Murphy SL, Kochanek KD. Deaths: Final Data for 1999. Hyattsville, Maryland: National vital statistics reports; 2001.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/(SICI)1097-0142(19980315)82:6<1197::AID-CNCR26>3.0.CO;2-0', 'is_inner': False, 'url': 'https://doi.org/10.1002/(sici)1097-0142(19980315)82:6<1197::aid-cncr26>3.0.co;2-0'}, {'type': 'PubMed', 'value': '9506368', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/9506368/'}]}
    2. Wingo PA, Ries LA, Rosenberg HM, Miller DS, Edwards BK. Cancer incidence and mortality, 1973–1995: a report card for the US Cancer. 1998;82:1197–207.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/jama.261.1.61', 'is_inner': False, 'url': 'https://doi.org/10.1001/jama.261.1.61'}, {'type': 'PubMed', 'value': '2908996', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/2908996/'}]}
    2. Pierce JP, Fiore MC, Novotny TE, Hatziandreu EJ, Davis RM. Trends in cigarette smoking in the United States. Projections to the year 2000. Jama. 1989;261:61–5.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/cncr.20953', 'is_inner': False, 'url': 'https://doi.org/10.1002/cncr.20953'}, {'type': 'PubMed', 'value': '15726545', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15726545/'}]}
    2. Muscat JE, Djordjevic MV, Colosimo S, Stellman SD, Richie JP Jr. Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Cancer. 2005;103:1420–6.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1158/1055-9965.EPI-04-0426', 'is_inner': False, 'url': 'https://doi.org/10.1158/1055-9965.epi-04-0426'}, {'type': 'PubMed', 'value': '15734965', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15734965/'}]}
    2. Schildkraut JM, Demark-Wahnefried W, Wenham RM, et al. IGF1 (CA)19 repeat and IGFBP3 -202 A/C genotypes and the risk of prostate cancer in Black and White men. Cancer Epidemiol Biomarkers Prev. 2005;14:403–8.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/archinte.163.1.49', 'is_inner': False, 'url': 'https://doi.org/10.1001/archinte.163.1.49'}, {'type': 'PubMed', 'value': '12523916', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/12523916/'}]}
    2. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003;163:49–56.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/1097-0142(20011115)92:10<2547::AID-CNCR1606>3.0.CO;2-K', 'is_inner': False, 'url': 'https://doi.org/10.1002/1097-0142(20011115)92:10<2547::aid-cncr1606>3.0.co;2-k'}, {'type': 'PubMed', 'value': '11745188', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/11745188/'}]}
    2. Cheng X, Chen VW, Steele B, et al. Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992–1997. Cancer. 2001;92:2547–54.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.2105/AJPH.92.7.1144', 'is_inner': False, 'url': 'https://doi.org/10.2105/ajph.92.7.1144'}, {'type': 'PMC', 'value': 'PMC1447205', 'is_inner': False, 'url': 'http://www.ncbi.nlm.nih.gov/pmc/articles/pmc1447205/'}, {'type': 'PubMed', 'value': '12084699', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/12084699/'}]}
    2. Jacobellis J, Cutter G. Mammography screening and differences in stage of disease by race/ethnicity. Am J Public Health. 2002;92:1144–50.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1097/00005650-199809000-00006', 'is_inner': False, 'url': 'https://doi.org/10.1097/00005650-199809000-00006'}, {'type': 'PubMed', 'value': '9749657', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/9749657/'}]}
    2. Klabunde CN, Potosky AL, Harlan LC, Kramer BS. Trends and black/white differences in treatment for nonmetastatic prostate cancer. Med Care. 1998;36:1337–48.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1097/00005650-199511000-00002', 'is_inner': False, 'url': 'https://doi.org/10.1097/00005650-199511000-00002'}, {'type': 'PubMed', 'value': '7475418', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/7475418/'}]}
    2. Schapira MM, McAuliffe TL, Nattinger AB. Treatment of localized prostate cancer in African-American compared with Caucasian men. Less use of aggressive therapy for comparable disease. Med Care. 1995;33:1079–88.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/jama.281.8.720', 'is_inner': False, 'url': 'https://doi.org/10.1001/jama.281.8.720'}, {'type': 'PubMed', 'value': '10052442', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/10052442/'}]}
    2. Riley GF, Potosky AL, Klabunde CN, Warren JL, Ballard-Barbash R. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison. Jama. 1999;281:720–6.
    1. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. In: N Engl J Med; 1999:1198–205.
    1. Demissie K, Oluwole OO, Balasubramanian BA, Osinubi OO, August D, Rhoads GG. Racial differences in the treatment of colorectal cancer: a comparison of surgical and radiation therapy between Whites and Blacks. In: Ann Epidemiol; 2004:215–21.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1200/JCO.2002.08.062', 'is_inner': False, 'url': 'https://doi.org/10.1200/jco.2002.08.062'}, {'type': 'PubMed', 'value': '12039925', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/12039925/'}]}
    2. Neugut AI, Fleischauer AT, Sundararajan V, et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol. 2002;20:2643–50.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '11419029', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/11419029/'}]}
    2. Sundararajan V, Grann VR, Jacobson JS, Ahsan H, Neugut AI. Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study. Cancer J. 2001;7:213–8.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/jama.294.14.1765', 'is_inner': False, 'url': 'https://doi.org/10.1001/jama.294.14.1765'}, {'type': 'PubMed', 'value': '16219879', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/16219879/'}]}
    2. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and Survival Disparities Among Black and White Patients With Breast Cancer. JAMA. 2005;294:1765–72.
    1. Wilt TJ, MacDonald R, Hagerty K, Schellhammer P, Kramer BS. Five-alpha-reductase Inhibitors for prostate cancer prevention. Cochrane Database Syst Rev. 2008:CD007091.
    1. Hoffman RM, Harlan LC, Klabunde CN, et al. Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study. In: J Gen Intern Med; 2003:845–53.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/cncr.11051', 'is_inner': False, 'url': 'https://doi.org/10.1002/cncr.11051'}, {'type': 'PubMed', 'value': '12491515', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/12491515/'}]}
    2. Shavers VL, Harlan LC, Stevens JL. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer. 2003;97:134–47.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1023/A:1015220420400', 'is_inner': False, 'url': 'https://doi.org/10.1023/a:1015220420400'}, {'type': 'PubMed', 'value': '12083631', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/12083631/'}]}
    2. Joslyn SA. Hormone receptors in breast cancer: racial differences in distribution and survival. Breast Cancer Res Treat. 2002;73:45–59.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/(SICI)1097-0142(19960415)77:8<1465::AID-CNCR7>3.0.CO;2-B', 'is_inner': False, 'url': 'https://doi.org/10.1002/(sici)1097-0142(19960415)77:8<1465::aid-cncr7>3.0.co;2-b'}, {'type': 'PubMed', 'value': '8608530', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/8608530/'}]}
    2. Gapstur SM, Dupuis J, Gann P, Collila S, Winchester DP. Hormone receptor status of breast tumors in black, Hispanic, and non-Hispanic white women. An analysis of 13,239 cases. Cancer. 1996;77:1465–71.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.2105/AJPH.77.3.351', 'is_inner': False, 'url': 'https://doi.org/10.2105/ajph.77.3.351'}, {'type': 'PMC', 'value': 'PMC1646891', 'is_inner': False, 'url': 'http://www.ncbi.nlm.nih.gov/pmc/articles/pmc1646891/'}, {'type': 'PubMed', 'value': '3812846', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/3812846/'}]}
    2. Beverly LN, Flanders WD, Go RC, Soong SJ. A comparison of estrogen and progesterone receptors in black and white breast cancer patients. Am J Public Health. 1987;77:351–3.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/cncr.21463', 'is_inner': False, 'url': 'https://doi.org/10.1002/cncr.21463'}, {'type': 'PubMed', 'value': '16208704', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/16208704/'}]}
    2. Stark AT, Claud S, Kapke A, Lu M, Linden M, Griggs J. Race modifies the association between breast carcinoma pathologic prognostic indicators and the positive status for HER-2/neu. Cancer. 2005;104:2189–96.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S1542-3565(04)00664-0', 'is_inner': False, 'url': 'https://doi.org/10.1016/s1542-3565(04)00664-0'}, {'type': 'PubMed', 'value': '15704049', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15704049/'}]}
    2. Gupta AK, Melton LJ 3rd, Petersen GM, et al. Changing trends in the incidence, stage, survival, and screen-detection of colorectal cancer: a population-based study. Clin Gastroenterol Hepatol. 2005;3:150–8.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1200/JCO.2005.02.1758', 'is_inner': False, 'url': 'https://doi.org/10.1200/jco.2005.02.1758'}, {'type': 'PubMed', 'value': '16365180', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/16365180/'}]}
    2. Lathan CS, Neville BA, Earle CC. The Effect of Race on Invasive Staging and Surgery in Non-Small-Cell Lung Cancer. J Clin Oncol. 2006;24:413–8.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever